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Are A-Changin’ . . . .*
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The article by Hadjipetrou et al. (1) describes a single
center’s experience treating symptomatic subclavian and
brachiocephalic obstructive disease with percutaneous an-
gioplasty and stenting. The report consists of 18 consecutive
patients, 4 with total occlusions, treated over a 48-month
period. Successful therapy with resolution of symptoms
without major complications was achieved in all patients.
Primary patency over a mean follow-up of 17 months was
100% and was objectively confirmed with noninvasive im-
aging.
See page 1238
The article provides a review of the literature regarding
surgical therapy and percutaneous therapy for brachioce-
phalic obstructive disease. The authors point out that
surgical therapy, the current “gold standard” of revascular-
ization of these vessels, has never been subjected to con-
trolled trials comparing percutaneous therapy or alternative
surgical techniques. The surgical experience in this field,
extending back several decades, is summarized including an
analysis of more recent results over the last 10 years.
The authors do not address the issue of “primary stent-
ing” (stent placement regardless of the balloon angioplasty
result) versus “provisional stenting” (stent placement only
for a suboptimal balloon angioplasty result), choosing in this
series to perform primary stenting. Currently, we do not
known whether placing a stent enhances a good balloon
angioplasty result. Primary stenting is associated with the
increased cost of the stent, the potential risk of implanting
a foreign body, and the potential for adverse effects from the
anticoagulant or antiplatelet regimen used to prevent stent
thrombosis. Although preliminary evidence in iliac arteries
suggests that provisional stenting can achieve comparable
results to primary stent placement (2), this will require
further investigation in other vascular territories and more
patients.
Hadjipetrou et al. (1) acknowledge the difficulty and inher-
ent limitation of comparing the results of disparate series of
patients and widely varying treatment modalities. However,
they make a convincing argument that primary stent therapy
of these brachiocephalic vessels is at least equal, if not
superior, to those reported for surgery. They emphasize that
the advantages of percutaneous intervention are realized by
fewer surgical and anesthesia related complications, less
procedure related morbidity and a shorter hospital stay.
The significance of this study lies not only in the excellent
results percutaneous intervention yields in this small num-
ber of patients; more important, the article reflects an
emerging shift in the traditional management of peripheral
arterial occlusive disease, whereby percutaneous and “endo-
vascular” therapies are replacing conventional surgical pro-
cedures. Examples of this changing paradigm are evident in
the management of aorto-iliac and renal artery occlusive
disease. In our hospital, conventional aorto-femoral bypass
and renal artery bypass are infrequent procedures, having
been almost completely replaced with percutaneous inter-
ventions. The most frequent indication, in our hospital, for
surgical bypass of iliac and renal artery lesions is a failed
intervention, usually as a result of the inability to cross a
total occlusion with a guidewire.
Not all physicians welcome the evolution of peripheral
vascular revascularization strategies from conventional sur-
gery to percutaneous “endovascular” procedures. General
and vascular surgeons may ultimately face a decreasing
demand for their services unless they obtain the necessary
skills to perform “endovascular” surgery. Although it is
prudent and appropriate for our surgical colleagues to
demand evidence of the safety and efficacy of these percu-
taneous procedures, it is inappropriate to impede the
progress of clinical trials, designed to expand the scope of
percutaneous intervention, for the sake of protecting self-
interest.
Peripheral vascular disease in the U.S. is underdiagnosed
and undertreated at great cost to patients and society in
terms of preventable morbidity and mortality. Increasing the
number of physicians who can care for these patients and
improving the safety and efficacy of therapeutic interven-
tions is clearly in the best interest of our patients. Unfortu-
nately, in many hospitals, “turf-wars” over credentials and
training requirements to provide these needed services
prevent many interested physicians from undertaking to
meet this demand for clinical services.
Recognizing the necessity for subspecialty societies to
provide guidelines specific to their specialty, the Society for
Cardiac Angiography and Intervention (SCAI) has recently
revised its guidelines for performing peripheral angioplasty
(3). The Society has adopted a “tiered” approach, which
facilitates entry into this field with “limited” certification
criteria to perform iliac and renal artery intervention while
concurrently maintaining the high standards established by
the AHA/ACC (American Heart Association/American
College of Cardiology) guidelines for “unrestricted” certifi-
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cation to perform peripheral vascular procedures. The key
element of this strategy is that procedures performed under
“limited” certification are counted to meet the necessary
criteria for “unrestricted” certification. This provision will
obviate the burdensome need for practicing physicians to
leave their practice for extended periods of time in order to
obtain the volume of cases required for certification.
Those who would restrict the numbers of physicians
capable of caring for these patients state that standards of
care will fall and patient care will be jeopardized by
facilitating entry into the field of interventional peripheral
vascular medicine. This is an untenable and negative point
of view that does not offer a solution to the problem of
meeting this underserved clinical need. Although subspe-
cialty societies are in the best position to determine the
specific needs and training requirements of their members,
the hospital is responsible for quality assurance. Standards
of care, measured by outcome reporting and procedural
volume requirements, should be established for each hospi-
tal and applied equally to all physicians, regardless of their
subspecialty. Temporary or conditional privileges to per-
form procedures may be granted to qualified physicians
(with outcomes assessed) to assure that an acceptable quality
of care is delivered.
The time has come to acknowledge the major role less
invasive procedures will play in the future management of
peripheral arterial occlusive disease and to responsibly facil-
itate the training and certification of physicians to provide
these services. If we are committed to improving patient
care, we cannot tolerate “protectionist” or “self-serving”
training requirements that do not offer solutions, but instead
preserve a “status quo” that benefits a few subspecialists to
the detriment of our patients.
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